# Asklepios BioPharmaceutical, Inc. — Form D

Asklepios BioPharmaceutical, Inc. of DURHAM, NC, a company, filed a Form D exempt-offering notice with the SEC on 2019-05-29. The offering totals $199.7M, of which $199.7M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2019-05-29
- Form: D
- Accession: 0001352189-19-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $199.7M
- Amount sold: $199.7M
- Minimum investment: $101K
- Investors: 33
- Date of first sale: 2019-04-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-340600

## Issuer

- Name: Asklepios BioPharmaceutical, Inc.
- CIK: 0001352189
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 20 TW ALEXANDER DRIVE, DURHAM, NC, 27709
- Phone: (919) 561-6210

## Officers, directors & promoters (11)

| Name | Role | Location |
| --- | --- | --- |
| Fred Cohen | Director | AUSTIN, TX |
| Javier Garcia | Director | Cambridge, MA |
| William Hawkins | Director | The Woodlands, TX |
| Sheila Mikhail | Director | Durham, NC |
| Jon Salveson | Director | Plymouth, MN |
| Richard Samulski | Director | Durham, NC |
| John Schilling | Director | Fort Worth, TX |
| Katherine Wood | Director | Fort Worth, TX |
| Timothy Ferguson | Executive Officer | Sylacauga, AL |
| Sheila Mikhail | Executive Officer | Durham, NC |
| Richard Samulski | Executive Officer | Durham, NC |

## More

- [CIK 1352189 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1352189&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001352189-19-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.